Research summary, original research, 2017

Eye lens dose correlations with personal dose equivalent and patient exposure in paediatric interventional cardiology performed with a fluoroscopic biplane system

Alejo L, Koren C, Corredoira E, Sánchez F, Bayón J, Serrada A, et al.. Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB). 2017

Read the original paper

In plain language

In two paediatric interventional cardiologists using a biplane system, eye lens dose was about 4-5 mSv per year and tracked closely with the over-apron dosimeter (about 0.38 of it), when the ceiling shield was rarely used.

At a glance

Type of study
Original research, Dosimetry measurement study
Who was studied
Interventional cardiologists
Size
n = 222 procedures
Summary based on
the abstract

What it found

  • Annual eye lens doses measured on goggles for the two paediatric cardiologists were about 4-5 mSv.

    Key figures: 4.13±0.93 and 4.98±1.28 mSv per year

  • Goggle (eye) dose correlated strongly with dose measured over the apron, at roughly 0.38 of the apron dose.

    Key figures: R2=0.89, ratio 0.38

  • Eye dose correlated only moderately with patient dose (kerma-area product).

    Key figures: R2=0.40, ratio 1.79 μSv Gy-1 cm-2

  • Per-procedure doses were about 102 μSv over the apron and 40 μSv on goggles.

    Key figures: 102±16 μSv apron; 40±9 μSv goggles

  • The ceiling-suspended shield was often not used during procedures.

Limits to keep in mind

Only two cardiologists at a single facility over one year, with frequent non-use of the ceiling shield, so the apron-to-eye ratio may not apply where shielding is used. Eye dose was estimated by dosimeters on goggles rather than directly at the lens.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.